首页> 外文期刊>The Journal of Urology >Endoluminal stent placement after percutaneous transluminal angioplasty in the treatment of post-transplant renal artery stenosis.
【24h】

Endoluminal stent placement after percutaneous transluminal angioplasty in the treatment of post-transplant renal artery stenosis.

机译:经皮腔内血管成形术后腔内支架置入术治疗移植后肾动脉狭窄。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE: We report our experience with endoluminal stent placement after percutaneous transluminal angioplasty for the treatment of post-transplant renal artery stenosis. MATERIALS AND METHODS: From October 1992 to September 1996, 8 stents were successfully implanted in 7 patients affected by resistant transplant renal artery stenosis. All transplanted kidneys were procured from cadaver donors. The patients were routinely evaluated with duplex sonography and the median interval between transplantation and stenosis detection was 7.4 months (range 0.5 to 17). When serious renal stenosis was diagnosed (greater than 50%), selected angiography and percutaneous transluminal angioplasty were performed. In 8 cases (7 patients) an endoluminal metallic Palmaz stent was placed in the site of the restenosis. One patient received 2 stents repeatedly positioned in different stenosis sites. RESULTS: No major complications occurred. Clinical outcome was positive in 5 patients (71.4%) and Stenosis recurred in 2 (28.5%) (less than 50% and less than 35%, respectively). Median followup after stent placement was 14.8 months (range 1 to 37). CONCLUSIONS: Percutaneous endoluminal stent procedures after resistant transplant renal artery stenosis or for ex novo treatment for severe anastomotic stenoses appears to be promising. Longer followup periods are necessary for true evaluation of this procedure.
机译:目的:我们报告我们的经验,经皮腔内血管成形术治疗腔内支架置入术后移植肾动脉狭窄。材料与方法:从1992年10月至1996年9月,成功地将8枚支架植入了7例患有抵抗力移植肾动脉狭窄的患者。所有移植的肾脏均从尸体捐赠者那里购买。对患者进行常规双相超声检查,移植和狭窄检测之间的中位间隔为7.4个月(范围0.5至17)。当诊断出严重的肾狭窄(大于50%)时,进行了选择的血管造影和经皮腔内血管成形术。在8例(7例患者)中,将腔内金属Palmaz支架置入再狭窄部位。一名患者接受了2个重复放置在不同狭窄部位的支架。结果:未发生重大并发症。 5例(71.4%)的临床结果为阳性,2例(28.5%)的狭窄复发(分别小于50%和小于35%)。支架置入后的中位随访时间为14.8个月(范围1至37)。结论:抵抗性移植肾动脉狭窄或严重的吻合口狭窄的从头治疗后,经皮腔内支架置入术似乎是有希望的。为了真正评估此程序,需要更长的随访时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号